Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 14 results.
User Information
Export Records
  1. 1.   Eribulin Regresses a Cisplatinum-resistant Rare-type Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft Mouse Model
  2. Yamamoto, Jun; Murata, Takuya; Sugisawa, Norihiko; Higuchi, Takashi; Tashiro, Yoshihiko; Nishino, Hiroto; Inubushi, Sachiko; Sun, Y U; Lim, Hyein; Miyake, Kentaro; Shimoya, Koichiro; Nomura, Tsunehisa; Kurebayashi, Junichi; Tanino, Hirokazu; Hozumi, Chihiro; Bouvet, Michael; Singh,Shree Ram; Endo, Itaru; Hoffman, Robert M
  3. Anticancer research. 2020, May; 40(5): 2475-2479.
  1. 2.   A Novel Anionic-phosphate-platinum Complex Effectively Targets a Cisplatinum-resistant Osteosarcoma in a Patient-derived Orthotopic Xenograft Mouse Model
  2. Igarashi, Kentaro; Kawaguchi, Kei; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Higuchi, Takashi; Taniguchi, Yuta; Yonezawa, Hirotaka; Araki, Yoshihiro; Morinaga, Sei; Misra,Sweta; Nelson, Scott D.; Dry, Sarah M.; Li, Yunfeng; Odani, Akira; Singh,Shree Ram; Tsuchiya, Hiroyuki; Hoffman, Robert M.
  3. Cancer genomics & proteomics. 2020, May-Jun; 17(3): 217-223.
  1. 3.   PPAR gamma Agonist Pioglitazone in Combination With Cisplatinum Arrests a Chemotherapy-resistant Osteosarcoma PDOX Model
  2. Higuchi, Takashi; Yamamoto, Jun; Sugisawa, Norihiko; Tashiro, Yoshihiko; Nishino, Hiroto; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Igarashi, Kentaro; Bouvet, Michael; Singh,Shree Ram; Tsuchiya, Hiroyuki; Hoffman, Robert M
  3. Cancer genomics & proteomics. 2020, Jan-Feb; 17(1): 35-40.
  1. 4.   Combination of Trabectedin With Oxaliplatinum and 5-Fluorouracil Arrests a Primary Colorectal Cancer in a Patient-derived Orthotopic Xenograft Mouse Model
  2. Zhu, Guangwei; Zhao, Ming; Han, Qinghong; Tan, Yuying; Sun, Y U; Bouvet, Michael; Singh,Shree Ram; Ye, Jianxin; Hoffman, Robert M
  3. Anticancer research. 2019, Nov; 39(11): 5999-6005.
  1. 5.   Tumor-targeting Salmonella typhimurium A1-R overcomes partial carboplatinum-resistance of a cancer of unknown primary (CUP)
  2. Miyake, Kentaro; Kiyuna, Tasuku; Miyake, Masuyo; Zhao, Ming; Wangsiricharoen, Sintawat; Kawaguchi, Kei; Zhang, Zhiying; Higuchi, Takashi; Razmjooei, Sahar; Li, Yunfeng; Nelson, Scott D.; Russell, Tara; Singh, Arun; Murakami, Takashi; Hiroshima, Yukihiko; Momiyama, Masashi; Matsuyama, Ryusei; Chishima, Takashi; Singh,Shree Ram; Chawla, Sant P.; Eilber, Fritz C.; Endo, Itaru; Hoffman, Robert M.
  3. TISSUE & CELL. 2018, OCT; 54: 144-149.
  1. 6.   Secretion of annexin A3 from ovarian cancer cells and its association with platinum resistance in ovarian cancer patients
  2. Yin, J.; Yan, X. D.; Yao, X.; Zhang, Y. L.; Shan, Y.; Mao, N.; Yang, Y. L.; Pan, L. Y.
  3. Journal of Cellular and Molecular Medicine. 2012, Feb; 16(2): 337-348.
  1. 7.   Synthesis and Biological Evaluation of ABCD Ring Fragments of the Kibdelones
  2. Sloman, D. L.; Mitasev, B.; Scully, S. S.; Beutler, J. A.; Porco, J. A.
  3. Angewandte Chemie-International Edition. 2011, Mar 7; 50(11): 2511-2515.
  1. 8.   Hypersusceptibility to cisplatin carcinogenicity in metallothionein-I/II double knockout mice: Production of hepatocellular carcinoma at clinically relevant doses
  2. Waalkes, M. P.; Liu, J.; Kasprzak, K. S.; Diwan, B. A.
  3. International Journal of Cancer. 2006, JUL 1; 119(1): 28-32.
  1. 9.   Role of GADD34 in modulation of cisplatin cytotoxicity
  2. Fishel, M. L.; Rabik, C. A.; Bleibel, W. K.; Li, X. M.; Moschel, R. C.; Dolan, M. E.
  3. Biochemical Pharmacology. 2006, JAN 12; 71(3): 239-247.
  1. 10.   Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer
  2. Zorn, K. K.; Bonome, T.; Gangi, L.; Chandramouli, G. V. R.; Awtrey, C. S.; Gardner, G. J.; Barrett, J. C.; Boyd, J.; Birrer, M. J.
  3. Clinical Cancer Research. 2005, SEP 15; 11(18): 6422-6430.
  1. 11.   Role of glutathione and nucleotide excision repair in modulation of cisplatin activity with O-6-benzylguanine
  2. Fishel, M. L.; Ganicsik, M. P.; Delaney, S. M.; Zuhowski, E. G.; Maher, V. M.; Karrison, T.; Moschel, R. C.; Egorin, M. J.; Dolan, M. E.
  3. Cancer Chemotherapy and Pharmacology. 2005, APR; 55(4): 333-342.
  1. 12.   Nitric oxide prodrugs and metallochemotherapeutics: JS-K and CB-3-100 enhance arsenic and cisplatin cytolethality by increasing cellular accumulation
  2. Liu, J.; Li, C. X.; Qu, W.; Leslie, E.; Bonifant, C. L.; Buzard, G. S.; Saavedra, J. E.; Keefer, L. K.; Waalkes, M. P.
  3. Molecular Cancer Therapeutics. 2004 3(6): 709-714.
  1. 13.   Chromium mapping in male mice reproductive glands exposed to CrCl3 using proton and X-ray synchrotron radiation microbeams
  2. Ortega, R.; Deves, G.; Bonnin-Mosbah, M.; Salome, M.; Susini, J.; Anderson, L. M.; Kasprzak, K. S.
  3. Nuclear Instruments & Methods in Physics Research Section B- Beam Interactions with Materials and Atoms. 2001 181: 485-488.
  1. 14.   Cisplatin exposure induces mitochondrial toxicity in pregnant rats and their fetuses
  2. Gerschenson, M.; Paik, C. Y.; Gaukler, E. L.; Diwan, B. A.; Poirier, M. C.
  3. Reproductive Toxicology. 2001 15(5): 525-531.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel